D Revicki

Summary

Affiliation: United BioSource Corporation
Country: USA

Publications

  1. pmc Development and psychometric assessment of the COPD and Asthma Sleep Impact Scale (CASIS)
    Robin F Pokrzywinski
    United BioSource Corporation, Bethesda, MD, USA
    Health Qual Life Outcomes 7:98. 2009
  2. pmc Exploratory and confirmatory factor analysis of the PROMIS pain quality item bank
    Dennis A Revicki
    Center for Health Outcomes Research, United BioSource Corporation, 7101 Wisconsin Ave, Suite 600, Bethesda, MD, 20814, USA
    Qual Life Res 23:245-55. 2014
  3. pmc Exploring factors influencing asthma control and asthma-specific health-related quality of life among children
    Pranav K Gandhi
    Department of Pharmacy Practice, School of Pharmacy, South College, Knoxville, TN, USA
    Respir Res 14:26. 2013
  4. pmc Review of patient-reported outcome measures in chronic hepatitis C
    Leah Kleinman
    United BioSource Corporation, Bethesda, MD, USA
    Health Qual Life Outcomes 10:92. 2012
  5. pmc Content validity and test-retest reliability of Patient Perception of Intensity of Urgency Scale (PPIUS) for overactive bladder
    Sherilyn M Notte
    United BioSource Corporation, 7101 Wisconsin Ave, Suite 600, Bethesda, MD 20814, USA
    BMC Urol 12:26. 2012
  6. doi Health-related quality of life outcomes of lenalidomide in transfusion-dependent patients with Low- or Intermediate-1-risk myelodysplastic syndromes with a chromosome 5q deletion: results from a randomized clinical trial
    Dennis A Revicki
    United BioSource Corporation, Bethesda, MD, USA
    Leuk Res 37:259-65. 2013
  7. doi Evaluation of the Sexual Desire Relationship Distress Scale (SDRDS) in women with hypoactive sexual desire disorder
    Dennis A Revicki
    Outcomes Research, United BioSource Corporation, Bethesda, MD 20814, USA
    J Sex Med 9:1344-54. 2012
  8. pmc Health related quality of life outcomes for unresectable stage III or IV melanoma patients receiving ipilimumab treatment
    Dennis A Revicki
    United BioSource Corporation, Bethesda, MD 20814, USA
    Health Qual Life Outcomes 10:66. 2012
  9. doi Humanistic and economic burden of generalized anxiety disorder in North America and Europe
    Dennis A Revicki
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD 20814, USA
    J Affect Disord 140:103-12. 2012
  10. doi Evaluating symptom outcomes in gastroparesis clinical trials: validity and responsiveness of the Gastroparesis Cardinal Symptom Index-Daily Diary (GCSI-DD)
    D A Revicki
    United BioSource Corporation, Bethesda, MD 20814, USA
    Neurogastroenterol Motil 24:456-63, e215-6. 2012

Detail Information

Publications93

  1. pmc Development and psychometric assessment of the COPD and Asthma Sleep Impact Scale (CASIS)
    Robin F Pokrzywinski
    United BioSource Corporation, Bethesda, MD, USA
    Health Qual Life Outcomes 7:98. 2009
    ..We developed and evaluated the psychometric performance of a patient-reported measure to assess the impact on sleep due to respiratory disease, the COPD and Asthma Sleep Impact Scale (CASIS)...
  2. pmc Exploratory and confirmatory factor analysis of the PROMIS pain quality item bank
    Dennis A Revicki
    Center for Health Outcomes Research, United BioSource Corporation, 7101 Wisconsin Ave, Suite 600, Bethesda, MD, 20814, USA
    Qual Life Res 23:245-55. 2014
    ..This study evaluated the factor structure of the patient-reported outcome measurement information system (PROMIS) pain quality item bank...
  3. pmc Exploring factors influencing asthma control and asthma-specific health-related quality of life among children
    Pranav K Gandhi
    Department of Pharmacy Practice, School of Pharmacy, South College, Knoxville, TN, USA
    Respir Res 14:26. 2013
    ....
  4. pmc Review of patient-reported outcome measures in chronic hepatitis C
    Leah Kleinman
    United BioSource Corporation, Bethesda, MD, USA
    Health Qual Life Outcomes 10:92. 2012
    ..The goal of this work was to provide recommendations for incorporation of PRO measurement of concepts that are relevant to the CHC experience into CHC clinical trial design...
  5. pmc Content validity and test-retest reliability of Patient Perception of Intensity of Urgency Scale (PPIUS) for overactive bladder
    Sherilyn M Notte
    United BioSource Corporation, 7101 Wisconsin Ave, Suite 600, Bethesda, MD 20814, USA
    BMC Urol 12:26. 2012
    ..The objectives of this study were to assess the content validity, test-retest reliability, and acclimation effect of the PPIUS in overactive bladder (OAB) patients...
  6. doi Health-related quality of life outcomes of lenalidomide in transfusion-dependent patients with Low- or Intermediate-1-risk myelodysplastic syndromes with a chromosome 5q deletion: results from a randomized clinical trial
    Dennis A Revicki
    United BioSource Corporation, Bethesda, MD, USA
    Leuk Res 37:259-65. 2013
    ..05). Clinically important changes in HRQL from baseline were observed at weeks 12, 24, 36, and 48 among RBC-TI≥26 week responders in both treatment groups. Lenalidomide treatment may be effective in improving HRQL outcomes...
  7. doi Evaluation of the Sexual Desire Relationship Distress Scale (SDRDS) in women with hypoactive sexual desire disorder
    Dennis A Revicki
    Outcomes Research, United BioSource Corporation, Bethesda, MD 20814, USA
    J Sex Med 9:1344-54. 2012
    ..The SDRDS is a 17-item PRO that includes items related to personal distress and distress related to relationship with partner...
  8. pmc Health related quality of life outcomes for unresectable stage III or IV melanoma patients receiving ipilimumab treatment
    Dennis A Revicki
    United BioSource Corporation, Bethesda, MD 20814, USA
    Health Qual Life Outcomes 10:66. 2012
    ..This report summarizes health-related quality of life (HRQL) outcomes for ipilimumab with/without gp100 vaccine compared to gp100 alone during the clinical trial's 12 week treatment induction period...
  9. doi Humanistic and economic burden of generalized anxiety disorder in North America and Europe
    Dennis A Revicki
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD 20814, USA
    J Affect Disord 140:103-12. 2012
    ..To review the humanistic and economic burden of generalized anxiety disorder (GAD)...
  10. doi Evaluating symptom outcomes in gastroparesis clinical trials: validity and responsiveness of the Gastroparesis Cardinal Symptom Index-Daily Diary (GCSI-DD)
    D A Revicki
    United BioSource Corporation, Bethesda, MD 20814, USA
    Neurogastroenterol Motil 24:456-63, e215-6. 2012
    ..The Gastroparesis Cardinal Symptom Index-Daily Diary (GCSI-DD) was developed to assess daily symptoms of gastroparesis. This study evaluated the validity and responsiveness of the GCSI-DD in patients with gastroparesis...
  11. doi Assessing the effect of darbepoetin alfa on patient-reported fatigue in chemotherapy-induced anemia in four randomized, placebo-controlled clinical trials
    Dennis A Revicki
    United BioSource Corporation, 7101 Wisconsin Avenue, Suite 600, Bethesda, MD 20814, USA
    Qual Life Res 21:311-21. 2012
    ..This analysis examined the effects of darbepoetin alfa on hemoglobin and fatigue outcomes in patients with cancer using latent growth curve modeling (LGM)...
  12. pmc Evaluating preference weights for the Asthma Symptom Utility Index (ASUI) across countries
    Emuella M Flood
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD, United States
    Health Qual Life Outcomes 4:51. 2006
    ..This study evaluated ASUI preference weights in Europe to determine whether the multi-attribute utility function, based on preferences from a US population, is generalizable across countries...
  13. pmc Translation and validation of non-English versions of the Ankylosing Spondylitis Quality of Life (ASQOL) questionnaire
    Lynda C Doward
    Galen Research, Manchester, UK
    Health Qual Life Outcomes 5:7. 2007
    ..The Ankylosing Spondylitis Quality of Life (ASQOL) questionnaire is a unidimensional, disease-specific measure developed in the UK and the Netherlands. This study describes its adaptation into other languages...
  14. pmc The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study
    Richard Shikiar
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD, USA
    Health Qual Life Outcomes 4:71. 2006
    ....
  15. pmc Symptom burden among patients with renal cell carcinoma (RCC): content for a symptom index
    Gale Harding
    UBC Center for Health Outcomes Research, Bethesda MD, USA
    Health Qual Life Outcomes 5:34. 2007
    ..Renal cell carcinoma (RCC) has multiple symptoms stemming from disease and treatments. There are few validated scales for evaluating RCC symptoms...
  16. ncbi Documenting the rationale and psychometric characteristics of patient reported outcomes for labeling and promotional claims: the PRO Evidence Dossier
    Dennis A Revicki
    Center for Health Outcomes Research, United BioSource Corporation, 7101 Wisconsin Ave, Suite 600, Bethesda, MD 20814, USA
    Qual Life Res 16:717-23. 2007
    ..The PRO Evidence Dossier may also be helpful to industry and academic researchers in identifying further information that will need to be developed to support the clinical development program and the PRO endpoints...
  17. ncbi Patient-based utilities for bipolar disorder-related health states
    Dennis A Revicki
    Center for Health Outcomes Research, The MEDTAP Institute at United BioSource Corporation, 7101 Wisconsin Avenue, Suite 600, Bethesda, MD 20814, USA
    J Affect Disord 87:203-10. 2005
    ..This study estimated health state utilities for hypothetical bipolar-related health states and patient's current health from bipolar I patients...
  18. doi Relationship between clinical response to therapy and health-related quality of life outcomes in patients with moderate to severe plaque psoriasis
    Dennis A Revicki
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD 20814, USA
    Dermatology 216:260-70. 2008
    ..However, the association between HRQOL outcomes and more substantial degrees of Psoriasis Area and Severity Index (PASI) response and physician and patient global ratings remains ill defined...
  19. pmc Responsiveness and minimal important differences for patient reported outcomes
    Dennis A Revicki
    Center for Health Outcomes Research, United BioSource Corporation, 7101 Wisconsin Ave, Suite 600, Bethesda, MD 20814, USA
    Health Qual Life Outcomes 4:70. 2006
    ..Responsiveness and MID must be demonstrated and documented for the particular study population, and these measurement characteristics are needed for PRO labeling and promotional claims...
  20. doi Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes
    Dennis Revicki
    Center for Health Outcomes Research, United BioSource Corporation, 7101 Wisconsin Avenue, Suite 600, Bethesda, MD 20814, USA
    J Clin Epidemiol 61:102-9. 2008
    ..The objective of this review is to summarize recommendations on methods for evaluating responsiveness and minimal important difference (MID) for patient-reported outcome (PRO) measures...
  21. ncbi Cost-effectiveness of evidence-based pharmacotherapy or cognitive behavior therapy compared with community referral for major depression in predominantly low-income minority women
    Dennis A Revicki
    Center for Health Outcomes Research, MEDTAP Institute, 7101 Wisconsin Avenue, Bethesda, MD 20814, USA
    Arch Gen Psychiatry 62:868-75. 2005
    ..Few clinical trials have evaluated interventions for major depressive disorder in samples of low-income minority women, and little is known about the cost-effectiveness of depression interventions for this population...
  22. ncbi Practical and philosophical issues surrounding a national item bank: if we build it will they come?
    Dennis A Revicki
    Center for Health Outcomes Research, United BioSource Corporation, 7101 Wisconsin Ave, Suite 600, Bethesda, MD 20814, USA
    Qual Life Res 16:167-74. 2007
    ....
  23. ncbi Impact of adalimumab treatment on patient-reported outcomes: results from a Phase III clinical trial in patients with moderate to severe plaque psoriasis
    Dennis A Revicki
    Center for Health Outcomes Research, United BioSource Corporation, 7101 Wisconsin Avenue, Bethesda, MD 20814, USA
    J Dermatolog Treat 18:341-50. 2007
    ..The effect of adalimumab on patient-reported outcomes (PROs) was evaluated in patients with moderate to severe psoriasis during the initial 16-week, double-blind period of a 52-week, Phase III, multicenter trial...
  24. ncbi Analyzing oncology clinical trial data using the Q-TWiST method: clinical importance and sources for health state preference data
    Dennis A Revicki
    Center for Health Outcomes Research, MEDTAP Institute, 7101 Wisconsin Avenue, Suite 600, Bethesda, MD 20814, USA
    Qual Life Res 15:411-23. 2006
    ..We also provide recommendations for measuring health utilities and for the design of Q-TWiST studies...
  25. ncbi Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis
    D Revicki
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD 20814, USA
    Br J Dermatol 158:549-57. 2008
    ..Health-related quality of life (HRQOL) and other patient-reported outcomes (PROs) are important in evaluating the impact of psoriasis and its treatment...
  26. ncbi Adalimumab reduces pain, fatigue, and stiffness in patients with ankylosing spondylitis: results from the adalimumab trial evaluating long-term safety and efficacy for ankylosing spondylitis (ATLAS)
    Dennis A Revicki
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, Maryland 20814, USA
    J Rheumatol 35:1346-53. 2008
    ..To evaluate the effect of adalimumab on pain, fatigue, and stiffness in patients with active ankylosing spondylitis (AS)...
  27. ncbi FDA draft guidance and health-outcomes research
    Dennis A Revicki
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD 20814, USA
    Lancet 369:540-2. 2007
  28. doi Health-related quality of life and utilities in primary-care patients with generalized anxiety disorder
    Dennis A Revicki
    Center for Health Outcomes Research, United BioSource Corporation, 7101 Wisconsin Ave, Suite 600, Bethesda, MD 20814, USA
    Qual Life Res 17:1285-94. 2008
    ..Generalized anxiety disorder (GAD) is prevalent and significantly impacts patient health-related quality of life (HRQL) and disability...
  29. pmc Predicting EuroQol (EQ-5D) scores from the patient-reported outcomes measurement information system (PROMIS) global items and domain item banks in a United States sample
    Dennis A Revicki
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD 20814, USA
    Qual Life Res 18:783-91. 2009
    ..We predicted EuroQoL (EQ-5D) index scores from patient-reported outcomes measurement information system (PROMIS) global items and domain item banks...
  30. pmc Development and psychometric analysis of the PROMIS pain behavior item bank
    Dennis A Revicki
    Center for Health Outcomes Research, United BioSource Corporation, 7101 Wisconsin Ave, Suite 600, Bethesda, MD 20814, USA
    Pain 146:158-69. 2009
    ..The PROMIS pain behavior item bank can be used to develop static short-form and dynamic measures of pain behavior for clinical studies...
  31. doi Reliability and validity of the National Eye Institute Visual Function Questionnaire-25 in patients with age-related macular degeneration
    Dennis A Revicki
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, Maryland 20814, USA
    Invest Ophthalmol Vis Sci 51:712-7. 2010
    ..To evaluate the psychometric characteristics of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) in patients with age-related macular degeneration (AMD) who participated in two clinical trials...
  32. pmc Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: results from a randomized, controlled Phase III study
    Dennis A Revicki
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, Maryland, USA
    Health Qual Life Outcomes 6:75. 2008
    ..To evaluate the impact of adalimumab on health-related quality of life (HRQOL) for patients with moderate to severe plaque psoriasis...
  33. doi Methods and issues associated with the use of quality-adjusted life-years
    Dennis A Revicki
    Center for Health Outcomes Research, United BioSource Corporation, 7101 Wisconsin Avenue, Suite 600, Bethesda, MD 20814, USA
    Expert Rev Pharmacoecon Outcomes Res 12:105-14. 2012
    ....
  34. doi Content validity of the Female Sexual Function Index (FSFI) in pre- and postmenopausal women with hypoactive sexual desire disorder
    Dennis A Revicki
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD 20814, USA
    J Sex Med 8:2237-45. 2011
    ..However, the content validity (relevance, clarity, comprehensiveness) of the instrument in women with hypoactive sexual desire disorder (HSDD) must also be established...
  35. pmc Psychometric characteristics of the short form 36 health survey and functional assessment of chronic illness Therapy-Fatigue subscale for patients with ankylosing spondylitis
    Dennis A Revicki
    Outcomes Research, United BioSource Corporation, Bethesda, MD, USA
    Health Qual Life Outcomes 9:36. 2011
    ..We evaluated the psychometric characteristics of the Short Form 36 (SF-36) Health Survey and the Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue subscale in patients with ankylosing spondylitis (AS)...
  36. ncbi Norms-based assessment of patient-reported outcomes associated with adalimumab monotherapy in patients with ankylosing spondylitis
    M Kimel
    United BioSource Corporation, Bethesda, MD 20814 4805, USA
    Clin Exp Rheumatol 29:624-32. 2011
    ..To compare the impact of ankylosing spondylitis (AS) on health-related quality of life (HRQL) and of adalimumab on initial and sustained improvement in HRQL for patients with active AS versus the general US population...
  37. ncbi Psychometric evaluation of the fatigue severity scale for use in chronic hepatitis C
    L Kleinman
    Center for Health Outcomes Research, MEDTAP International, Inc, Bethesda, MD, USA
    Qual Life Res 9:499-508. 2000
    ..76 and r = -0.76 respectively). Correlations with other SF-36 subscales were moderate (r = -0.46 to r = -0.67, all p < 0.0001). In summary, the FSS possesses good psychometric properties...
  38. ncbi Adalimumab plus methotrexate improved SF-36 scores and reduced the effect of rheumatoid arthritis (RA) on work activity for patients with early RA
    Miriam Kimel
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, Maryland 20814, USA
    J Rheumatol 35:206-15. 2008
    ..To compare the effect of adalimumab plus methotrexate (MTX) versus MTX monotherapy on health-related quality of life (HRQOL) and work activities in patients with early rheumatoid arthritis (RA)...
  39. doi Measurement of non-restorative sleep in insomnia: A review of the literature
    Margaret K Vernon
    United BioSource Corporation, Center for Health Outcomes Research, 7101 Wisconsin Avenue, Suite 600, Bethesda, MD 20814, USA
    Sleep Med Rev 14:205-12. 2010
    ..The objective of this literature review was to identify PROs used in insomnia populations that purport to measure NRS, and to evaluate their psychometric characteristics...
  40. ncbi Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q
    K Coyne
    MEDTAP International, Inc, Bethesda, MD 20814, USA
    Qual Life Res 11:563-74. 2002
    ..Currently, no OAB-specific questionnaires exist to evaluate all symptoms of OAB; thus we sought to evaluate the psychometric properties of a newly developed OAB HRQL questionnaire...
  41. ncbi Development and validation of a disease-specific treatment satisfaction questionnaire for gastro-oesophageal reflux disease
    K S Coyne
    MEDTAP International, Bethesda, MD 20814, USA
    Aliment Pharmacol Ther 18:907-15. 2003
    ..Currently, no disease-specific, patient-based, treatment satisfaction instruments related to gastro-oesophageal reflux disease exist...
  42. ncbi Atopic dermatitis is associated with a decrement in health-related quality of life
    Gwendoline Kiebert
    MEDTAP International, 7101 Wisconsin Avenue, Suite 600, Bethesda, MD 20814, USA
    Int J Dermatol 41:151-8. 2002
    ..Although atopic dermatitis is a chronic skin disease that can have a major impact on a patient's life, the burden of illness associated with this condition has not been well characterized...
  43. ncbi Clinical assessment of asthma symptom control: review of current assessment instruments
    Dennis Revicki
    Center for Health Outcomes Research, MEDTAP Institute, Bethesda, MD, USA
    J Asthma 43:481-7. 2006
    ....
  44. ncbi Costs of bipolar disorder
    Leah Kleinman
    MEDTAP International Inc, Bethesda, Maryland, USA
    Pharmacoeconomics 21:601-22. 2003
    ..Intangible costs such as family burden and impaired health-related quality of life are common, although it has proved difficult to attach monetary values to these costs...
  45. ncbi Integrating preferences into health status assessment for amyotrophic lateral sclerosis: the ALS Utility Index
    Kathleen Beusterien
    MEDTAP International, Bethesda, Maryland 20814, USA
    Amyotroph Lateral Scler Other Motor Neuron Disord 6:169-76. 2005
    ..06 x (A1 x A2 x A3 x A4) - 0.06 on a scale where 0.0 reflects death and 1.0 reflects healthy. This study provides a useful tool for classifying ALS patients and determining a general public-based utility score for ALS health states...
  46. ncbi Patient-reported outcomes assessment in cancer trials: taking stock, moving forward
    Joseph Lipscomb
    Emory University, Atlanta, GA 30322, USA
    J Clin Oncol 25:5133-40. 2007
    ....
  47. ncbi Analysis and interpretation of results based on patient-reported outcomes
    Jeff A Sloan
    Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA
    Value Health 10:S106-15. 2007
    ..g.,missing data, multiplicity, null results etc.). The manuscript provides key literature for existing resources and proposes new guidelines...
  48. ncbi Interpreting and reporting results based on patient-reported outcomes
    Dennis A Revicki
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD, USA
    Value Health 10:S116-24. 2007
    ..Clinical trial reports need to be comprehensive, clear, and sufficient to enable any reader to understand the methods, PRO measures, statistical analysis, and results...
  49. ncbi Divalproex sodium versus olanzapine in the treatment of acute mania in bipolar disorder: health-related quality of life and medical cost outcomes
    Dennis A Revicki
    Center for Outcomes Research, MEDTAP International, Bethesda, MD 20814, USA
    J Clin Psychiatry 64:288-94. 2003
    ..This study compares the clinical, health-related quality of life (HRQL), and economic outcomes of divalproex and olanzapine in the treatment of acute mania associated with bipolar disorder...
  50. ncbi Improved health-related quality of life for patients with active rheumatoid arthritis receiving rituximab: Results of the Dose-Ranging Assessment: International Clinical Evaluation of Rituximab in Rheumatoid Arthritis (DANCER) Trial
    Philip J Mease
    Seattle Rheumatology Associates, Seattle, WA 98104, USA
    J Rheumatol 35:20-30. 2008
    ....
  51. ncbi Reliability and validity of the social integration survey (SIS) in patients with schizophrenia
    Ariane K Kawata
    United BioSource Corporation, Center for Health Outcomes Research, 7101 Wisconsin Ave, Suite 600, Bethesda, MD 20814, USA
    Qual Life Res 17:123-35. 2008
    ..Schizophrenia-related impairments impact functional status and health-related quality of life. The Social Integration Survey (SIS) measures social functioning outcomes in schizophrenia from patient and informant perspectives...
  52. doi Reliability, validity, and responsiveness of the daily sleep interference scale among diabetic peripheral neuropathy and postherpetic neuralgia patients
    Margaret K Vernon
    United BioSource Corporation, Center for Health Outcomes Research, Bethesda, Maryland 20814, USA
    J Pain Symptom Manage 36:54-68. 2008
    ..The DSIS demonstrated robust test-retest reliability, good construct and discriminant validity and responsiveness in painful DPN and PHN patients. A 1-2 point change on the DSIS might be interpreted as an important difference...
  53. ncbi Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-Reported Outcomes Measurement Information System (PROMIS)
    Bryce B Reeve
    National Cancer Institute, NIH, Bethesda, Maryland 20892, USA
    Med Care 45:S22-31. 2007
    ..The construction and evaluation of item banks to measure unidimensional constructs of health-related quality of life (HRQOL) is a fundamental objective of the Patient-Reported Outcomes Measurement Information System (PROMIS) project...
  54. ncbi Adalimumab treatment is associated with improvement in health-related quality of life in psoriasis: patient-reported outcomes from a phase II randomized controlled trial
    Richard Shikiar
    Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    J Dermatolog Treat 18:25-31. 2007
    ..Psoriasis substantially impairs the health-related quality of life (HRQOL) of patients, and a comprehensive evaluation of treatment includes HRQOL measures...
  55. ncbi The patient experience of depression and remission: focus group results
    Lori Frank
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, Maryland, USA biosource com
    J Nerv Ment Dis 195:647-54. 2007
    ..Results suggest that new measures of treatment outcome should encompass irritability, anger, and ability to cope with life stressors...
  56. ncbi Assessing symptoms in gastroesophageal reflux disease: how well do clinicians' assessments agree with those of their patients?
    Elaine McColl
    Centre for Health Services Research, School of Population and Health Sciences, University of Newcastle upon Tyne, 21 Claremont Place, Newcastle upon Tyne NE2 4AA, United Kingdom
    Am J Gastroenterol 100:11-8. 2005
    ..This study aimed to determine the extent of agreement between clinicians and patients regarding assessments of reflux symptom severity in patients with gastroesophageal reflux disease...
  57. ncbi Cross-cultural development and validation of a patient self-administered questionnaire to assess quality of life in upper gastrointestinal disorders: the PAGI-QOL
    Christine de la Loge
    Mapi Values, Lyon, France
    Qual Life Res 13:1751-62. 2004
    ....
  58. ncbi The impact of urinary urgency and frequency on health-related quality of life in overactive bladder: results from a national community survey
    Karin S Coyne
    MEDTAP International, Bethesda, MD 20814, USA
    Value Health 7:455-63. 2004
    ..Most attention to OAB's impact on health-related quality of life (HRQL), however, has focused on urge incontinence. The objective of this study was to evaluate the burden of OAB, specifically urinary urgency and frequency on HRQL...
  59. ncbi Responsiveness and interpretation of a symptom severity index specific to upper gastrointestinal disorders
    Dennis A Revicki
    Center for Health Outcome Research, MEDTAP International, Bethesda, MD 20814, USA
    Clin Gastroenterol Hepatol 2:769-77. 2004
    ..This study evaluates responsiveness of the Patient Assessment of Gastrointestinal Disorders-Symptom Severity Index (PAGI-SYM) in gastroesophageal reflux disease (GERD) and dyspepsia...
  60. ncbi The link between health-related quality of life and clinical symptoms among children with attention-deficit hyperactivity disorder
    Louis S Matza
    MEDTAP International, Inc, Bethesda, Maryland, USA
    J Dev Behav Pediatr 25:166-74. 2004
    ..The findings suggest that HRQL instruments can add important information to efficacy measures in clinical trials of ADHD treatment...
  61. ncbi Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms
    Dennis A Revicki
    Center for Health Outcomes Research, MEDTAP International, Inc, Bethesda, MD 20814, USA
    Qual Life Res 13:833-44. 2004
    ..Patient-rated symptom assessments are needed for evaluating the effectiveness of medical treatments and for monitoring outcomes in gastroparesis...
  62. ncbi Depression with atypical features in the National Comorbidity Survey: classification, description, and consequences
    Louis S Matza
    MEDTAP International, Inc, Bethesda, MD 20814, USA
    Arch Gen Psychiatry 60:817-26. 2003
    ..The current study was conducted to increase understanding of atypical depression diagnosed using only the reversed vegetative symptoms of hypersomnia and hyperphagia...
  63. ncbi The impact of treatment for gastro-oesophageal reflux disease on health-related quality of life: a literature review
    Manishi Prasad
    MEDTAP International, Bethesda, MD 20814, USA
    Pharmacoeconomics 21:769-90. 2003
    ..Although there is evidence that treatment for GORD does improve symptoms and HR-QOL outcomes, further research is needed to more completely understand the value of medical therapy for GORD...
  64. ncbi Treating depression in predominantly low-income young minority women: a randomized controlled trial
    Jeanne Miranda
    Health Services Research Center, University of California at Los Angeles Neuropsychiatric Institute, CA 90024, USA
    JAMA 290:57-65. 2003
    ..Little is known about the effectiveness of guideline-based care for depression with impoverished minority women, most of whom do not seek care...
  65. ncbi Health-related quality-of-life outcomes of sirolimus-treated kidney transplant patients after elimination of cyclosporine A: results of a 2-year randomized clinical trial
    Rainer Oberbauer
    Allgemeines Krankenhaus, Wien, Austria
    Transplantation 75:1277-85. 2003
    ..This study compared 2-year health-related quality-of-life (HRQL) outcomes of sirolimus (SRL)-treated kidney transplant patients after elimination of cyclosporine A (CsA) to patients continuing on a combined CsA and SRL regimen...
  66. ncbi A cost-effectiveness clinical decision analysis model for treatment of Schizophrenia
    Cynthia S Palmer
    Center for Organization and Delivery Studies, Agency for Health Care Policy and Research, Rockville, MD, USA
    Arch Med Res 33:572-80. 2002
    ....
  67. pmc Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study
    Carol E Koro
    Pharmaceutical Health Services Research Department, School of Pharmacy, University of Maryland, Baltimore, MD 21201, USA
    BMJ 325:243. 2002
    ..To quantify the association between olanzapine and diabetes...
  68. ncbi Consistent patient-reported outcomes
    Dennis A Revicki
    Value Health 5:295-6. 2002
  69. ncbi Assessing meaningful change in quality of life over time: a users' guide for clinicians
    Mirjam A G Sprangers
    Department of Medical Psychology, Academic Medical Center, University of Amsterdam, The Netherlands
    Mayo Clin Proc 77:561-71. 2002
    ....
  70. ncbi Incorporating quality of life measures in HIV clinical trials
    Maria K Lin
    Department of International Health, School of Medicine, Johns Hopkins University, Baltimore, Maryland 21205, USA
    HIV Clin Trials 3:202-18. 2002
    ..We discuss the criteria for selecting and implementing HRQL instruments to optimize the usefulness of HRQL assessments in clinical studies...
  71. ncbi Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial
    Dennis A Revicki
    Center for Health Outcomes Research, MEDTAP International, 7101 Wisconsin Avenue, Suite 600, Bethesda, MD 20814, USA
    J Affect Disord 86:183-93. 2005
    ..The clinical, quality of life (QOL), and medical cost outcomes of treatment with divalproex were compared with lithium in patients with bipolar I disorder over 1 year...
  72. ncbi Bipolar disorder and health-related quality of life : review of burden of disease and clinical trials
    Dennis A Revicki
    Center for Health Outcomes Research, The MEDTAP Institute at United BioSource Corporation, Bethesda, Maryland 20814, USA biosource com
    Pharmacoeconomics 23:583-94. 2005
    ..HR-QOL outcome data may be useful in informing psychiatrists, patients and patient family members of the effects of treatment for bipolar disorder on patients' everyday lives, functioning and wellbeing...
  73. ncbi Efficacy of olanzapine and ziprasidone for the treatment of schizophrenia: a systematic review
    Louis S Matza
    The MEDTAP Institute at UBC, Bethesda, Maryland 20814, USA
    CNS Drugs 19:499-515. 2005
    ..Firm conclusions regarding the comparison between olanzapine and ziprasidone require additional published trials on ziprasidone, particularly in direct comparison with olanzapine...
  74. ncbi National health preference data: a useful resource for health services research
    Dennis A Revicki
    Med Decis Making 26:310-2. 2006
  75. pmc Measuring changes in functional status among patients with schizophrenia: the link with cognitive impairment
    Louis S Matza
    Center for Health Outcomes Research at UBC, 7101 Wisconsin Ave, Suite 600, Bethesda, MD 20814, USA
    Schizophr Bull 32:666-78. 2006
    ..When creating new functional outcomes measures for assessment of patients with schizophrenia, responsiveness to change in CIAS should be evaluated as part of the development and validation process...
  76. ncbi Economics of atypical antipsychotics in bipolar disorder: a review of the literature
    Rachael L Fleurence
    United BioSource Corporation, Health Care Analytics Group, Bethesda, Maryland 20814, USA
    CNS Drugs 20:591-9. 2006
    ..A better understanding of the complex interplay between effectiveness, safety, quality of life, adherence and resource use should ultimately contribute to improving the treatment of bipolar disorder...
  77. ncbi Validation issues in questionnaires for diagnosis and monitoring of gastroesophageal reflux disease in children
    Leah Kleinman
    United BioSource Corporation, Center for Health Outcomes Research, Seattle, WA 98121, USA
    Curr Gastroenterol Rep 8:230-6. 2006
    ..Measures of pediatric GERD symptoms include the GERQ, GERQ-R, and GSQ. These measures have advantages and disadvantages with regard to feasibility, reliability, and validity. Questionnaires are lacking for children older than 4 years...
  78. ncbi The infant gastroesophageal reflux questionnaire revised: development and validation as an evaluative instrument
    Leah Kleinman
    Center for Health Outcomes Research, United BioSource Corporation, Seattle, Washington 98121, USA
    Clin Gastroenterol Hepatol 4:588-96. 2006
    ..We revised the Infant Gastroesophageal Reflux Questionnaire (I-GERQ) on the basis of information from parents of infants with GERD and physicians and subjected it to a psychometric evaluation...
  79. ncbi Impact of omalizumab on quality-of-life outcomes in patients with moderate-to-severe allergic asthma
    Kimberly Niebauer
    Center for Health Outcomes Research, The MEDTAP Institute at United BioSource Corporation, Bethesda, Maryland 20814, USA
    Ann Allergy Asthma Immunol 96:316-26. 2006
    ..Omalizumab has recently demonstrated clinical efficacy and safety in treating IgE-mediated asthma...
  80. ncbi Is a family equal to the sum of its parts? Estimating family-level well-being for cost-effectiveness analysis
    Amy E Bonomi
    Puget Sound Center for Health Studies, Group Health Cooperative, 1730 Minor Avenue, Suite 1600 Seattle, WA 98101 2903, USA
    Qual Life Res 14:1127-33. 2005
    ..Using the health plan as a working frame of reference, we explore conceptual issues related to estimating effectiveness at the level of the family for use in CEA...
  81. ncbi Psychometric validation of the child health questionnaire (CHQ) in a sample of children and adolescents with attention-deficit/hyperactivity disorder
    Anne M Rentz
    Center for Health Outcomes Research, MEDTAP International, Bethesda, MD 20814, USA
    Qual Life Res 14:719-34. 2005
    ..Study results indicate the CHQ-PF50 is reliable, valid, and responsive to change in ADHD symptoms, suggesting it may provide a means of assessing HRQL outcomes associated with treatments for ADHD...
  82. ncbi Assessment of health state utilities for attention-deficit/hyperactivity disorder in children using parent proxy report
    Louis S Matza
    MEDTAP International, Inc, Center for Health Outcomes Research, Bethesda, MD 20814, USA
    Qual Life Res 14:735-47. 2005
    ..03). Results suggest that parent SG interviews are a feasible and useful method for obtaining utility scores that can be used in cost-effectiveness models of ADHD treatment...
  83. ncbi Depression and health-related quality of life for low-income African-American women in the U.S
    Lori B Frank
    Center for Health Outcomes Research, The MEDTAP Institute at UBC, 7101 Bethesda, MD, USA
    Qual Life Res 14:2293-301. 2005
    ..Results indicate the substantial HRQL impact of depression among low-income young African-American women with depression...
  84. ncbi Patient satisfaction with budesonide Turbuhaler versus triamcinolone acetonide administered via pressurized metered-dose inhaler in a managed care setting
    Kevin B Weiss
    Northwestern University Medical School, Chicago, Illinois, USA
    J Asthma 42:769-76. 2005
    ..Patients treated with budesonide were significantly more satisfied and compliant with their inhaled corticosteroid regimen compared with patients treated with triamcinolone acetonide...
  85. ncbi Exploration of the value of health-related quality-of-life information from clinical research and into clinical practice
    Gordon H Guyatt
    Department of Clinical Epidemiology and Biostatistics, McMaster University and Health Sciences Center, Hamilton, ON L8N 3Z5, Canada
    Mayo Clin Proc 82:1229-39. 2007
    ..Further investigation is warranted to confirm these observations and to define the particular combination of methods and settings most likely to yield important benefits...
  86. ncbi Vision-specific instruments for the assessment of health-related quality of life and visual functioning: a literature review
    Mary Kay Margolis
    MEDTAP International, Inc, Bethesda, Maryland 20814, USA
    Pharmacoeconomics 20:791-812. 2002
    ....
  87. ncbi Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations
    Robert H Dworkin
    Department of Anesthesiology, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA
    J Pain 9:105-21. 2008
    ..Provisional benchmarks for identifying clinically important changes in specific outcome measures that can be used for outcome studies of treatments for chronic pain are proposed...
  88. ncbi Peginterferon alpha-2a (40kD) [Pegasys] improves HR-QOL outcomes compared with unmodified interferon alpha-2a [Roferon-A]: in patients with chronic hepatitis C
    Jens Rasenack
    Klinikum der Albert Ludwigs Universität, Freiburg, Germany
    Pharmacoeconomics 21:341-9. 2003
    ..Treatment with peginterferon alpha-2a (40kD) provides an improved sustained response over unmodified interferon alpha-2a...
  89. ncbi Rhinitis Symptom Utility Index (RSUI) in Chinese subjects: a multiattribute patient-preference approach
    Phoebe S Y Lo
    Division of Otorhinolaryngology, Department of Surgery, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China
    Qual Life Res 15:877-87. 2006
    ..This study aimed to determine whether the Chinese RSUI could adopt the US-based multi-attribute utility function (MAUF) in scoring rhinitis symptoms...
  90. ncbi The impact of diabetic retinopathy: perspectives from patient focus groups
    Karin S Coyne
    MEDTAP International, Bethesda, MD 20814, USA
    Fam Pract 21:447-53. 2004
    ..Diabetic retinopathy (DR) affects 50-85% of people with diabetes and may result in visual impairment or blindness...
  91. ncbi Evaluating effects of method of administration on Walking Impairment Questionnaire
    Karin S Coyne
    MEDTAP International, 7101 Wisconsin Avenue, Suite 600, Bethesda, MD 20814, USA
    J Vasc Surg 38:296-304. 2003
    ..Currently this questionnaire is validated for interviewer administration only. Since this can be burdensome in a large clinical trial, we examined the effects of alternative methods of administration on patient responses on the WIQ...
  92. ncbi Validation of the revised Patient Perception of Migraine Questionnaire: measuring satisfaction with acute migraine treatment
    Dennis A Revicki
    Center for Health Outcomes Research, MEDTAP Institute at UBC, Bethesda, MD 20814, USA
    Headache 46:240-52. 2006
    ..To evaluate the psychometric properties of the revised Patient Perception of Migraine Questionnaire (PPMQ-R), which measures satisfaction with migraine treatment...
  93. ncbi Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patients
    David Bernstein
    North Shore University Hospital, 300 Community Drive, Manhasset, NY 11030, USA
    Hepatology 35:704-8. 2002
    ..In conclusion, sustained virologic response is associated with improvements in quality of life in patients with or without advanced liver disease. This parameter may be an important consideration in maximizing treatment adherence...